Drug Trial Radar · NCT03987620
Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
Last checked: Nov 20, 2026Latest source record: Sep 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
455
Actual
Start
Jun 7, 2019
Primary completion
Mar 29, 2020
Study completion Apr 29, 2020
Sponsor
- Lead sponsor
- Scynexis, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 17, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, randomized, multicenter, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral Ibrexafungerp (SCY-078) compared to placebo in female subjects 12 years and older with AVVC.
Conditions
- Candida Vulvovaginitis
Interventions
IbrexafungerpDrug
Ibrexafungerp 300mg BID for one day
PlaceboDrug
Matching Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Cure (Complete Resolution of Signs and Symptoms)Time frame: Day 8-14
Locations
41 sites in 2 countries. Site status is shown where the registry gives one.
Mesa OB-GYN
Mesa, Arizona
Red Rocks OBGYN
Lakewood, Colorado
Planned Parenthood Southern New England
New Haven, Connecticut
New Generation Medical Research
Hialeah, Florida
Healthcare Clinical Data Inc
North Miami, Florida
Physician Care Clinical Research LLC
Sarasota, Florida
CCT LLC - A VitaLink Company- PPDS
West Palm Beach, Florida
Mount Vernon Clinical Research, LLC
Sandy Springs, Georgia
Fellows Research Alliance Inc
Savannah, Georgia
Rosemark Women Care Specialists
Idaho Falls, Idaho
Praetorian Pharmaceutical Research, LLC
Marrero, Louisiana
North County Health Center, Planned Parenthood of the St. Louis Region and Southwest Missouri
Florissant, Missouri
Clinical Research Center Of Nevada
Las Vegas, Nevada
Planned Parenthood North Central Southern New Jersey (PPNCSNJ)
Hackensack, New Jersey
Carolina Institute for Clinical Research - M3 Wake Research
Fayetteville, North Carolina
Obstetrics and Gynecology Associates of Erie, PC
Erie, Pennsylvania
Planned Parenthood Southeastern Pennsylvania The Elizabeth Blackwell Health Center
Philadelphia, Pennsylvania
Fellows Research Alliance Inc
Bluffton, South Carolina
Chattanooga Medical Research Inc
Chattanooga, Tennessee
Signature GYN Services, PLLC
Fort Worth, Texas
Brownstone Clinical Trials, LLC
Irving, Texas
Multiprofile Hospital for Active Treatment -Asenovgrad EOOD
Asenovgrad, Bulgaria
MHAT Puls AD - PPDS
Blagoevgrad, Bulgaria
Multiprofile Hospital for Active Treatment - Chirpan EOOD
Chirpan, Bulgaria
Medical Center Asklepii OOD
Dupnitsa, Bulgaria
Diagnostic-Consultative Center I-Gabrovo EOOD
Gabrovo, Bulgaria
Multiprofile Hospital For Active Treatment Dr Tota Venkova
Gabrovo, Bulgaria
Multiprofile Hospital for Active Treatment Sv. Ivan Rilski - Gorna Oryahovitsa EOOD
Gorna Oryahovitsa, Bulgaria
Multiprofile Hospital for Active Treatment- Sveti Nikolay Chudotvoretz - LOM EOOD
Lom, Bulgaria
Multiprofile Hospital for Active Treatment - Prof. Dr. Paraskev Stoyanov AD
Lovech, Bulgaria
MHAT Stamen Iliev AD
Montana, Bulgaria
Multiprofile Hospital For Active Treatment - Pazardzhik AD
Pazardzhik, Bulgaria
Multiprofile Hospital for Active Treatment Trimontsium OOD
Plovdiv, Bulgaria
Multiprofile Hospital for Active Treatment - Samokov EOOD
Samokov, Bulgaria
Medical Center-1-Sevlievo EOOD
Sevlievo, Bulgaria
Multiprofile Hospital for Active Treatment Shumen
Shumen, Bulgaria
Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD
Smolyan, Bulgaria
Medical Center Excelsior OOD - PPDS
Sofia, Bulgaria
Diagnostic Consultative CTR - XX - Sofia - EOOD
Sofia, Bulgaria
Medical center Vip Clinic OOD
Sofia, Bulgaria
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.